BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27633869)

  • 1. Novel cardiac nuclear magnetic resonance method for noninvasive assessment of myocardial fibrosis in hemodialysis patients.
    Graham-Brown MP; March DS; Churchward DR; Stensel DJ; Singh A; Arnold R; Burton JO; McCann GP
    Kidney Int; 2016 Oct; 90(4):835-44. PubMed ID: 27633869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.
    Rutherford E; Talle MA; Mangion K; Bell E; Rauhalammi SM; Roditi G; McComb C; Radjenovic A; Welsh P; Woodward R; Struthers AD; Jardine AG; Patel RK; Berry C; Mark PB
    Kidney Int; 2016 Oct; 90(4):845-52. PubMed ID: 27503805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
    Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
    BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping.
    Xu H; Peng W; Yang Z; Zhang Y; Xia C; Li Z; Xu R; Guo Y
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):23. PubMed ID: 33691727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cardiac magnetic resonance imaging study of long-term and incident hemodialysis patients.
    Thompson RB; Raggi P; Wiebe N; Ugander M; Nickander J; Klarenbach SW; Thompson S; Tonelli M;
    J Nephrol; 2019 Aug; 32(4):615-626. PubMed ID: 30778918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients.
    Graham-Brown MP; Rutherford E; Levelt E; March DS; Churchward DR; Stensel DJ; McComb C; Mangion K; Cockburn S; Berry C; Moon JC; Mark PB; Burton JO; McCann GP
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):21. PubMed ID: 28238284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of B-type natriuretic peptide (BNP) and dialysis vintage with CMRI-derived cardiac indices in stable hemodialysis patients with a preserved left ventricular ejection fraction.
    Han X; He F; Cao Y; Li Y; Gu J; Shi H
    Int J Cardiovasc Imaging; 2020 Nov; 36(11):2265-2278. PubMed ID: 32686028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of native T1 mapping in the prediction of major adverse cardiovascular events in hemodialysis patients.
    Qin L; Gu S; Xiao R; Liu P; Yan F; Yu H; Yang W
    Eur Radiol; 2022 Oct; 32(10):6878-6890. PubMed ID: 35554644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in Cardiac Deformation, Timing of Contraction and Relaxation, and Early Myocardial Fibrosis Accompany the Apparent Recovery of Acute Stress-Induced (Takotsubo) Cardiomyopathy: An End to the Concept of Transience.
    Schwarz K; Ahearn T; Srinivasan J; Neil CJ; Scally C; Rudd A; Jagpal B; Frenneaux MP; Pislaru C; Horowitz JD; Dawson DK
    J Am Soc Echocardiogr; 2017 Aug; 30(8):745-755. PubMed ID: 28599831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between right ventricular T
    Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance.
    Graham-Brown MP; Singh AS; Gulsin GS; Levelt E; Arnold JA; Stensel DJ; Burton JO; McCann GP
    BMC Cardiovasc Disord; 2018 Jul; 18(1):145. PubMed ID: 30005636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Features of cardiovascular magnetic resonance native T1 mapping in maintenance hemodialysis patients and their related factors.
    Zhang C; Yao L; Liu M; Zhou Y
    Ren Fail; 2024 Dec; 46(1):2310078. PubMed ID: 38293793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis.
    Lee SP; Lee W; Lee JM; Park EA; Kim HK; Kim YJ; Sohn DW
    Radiology; 2015 Feb; 274(2):359-69. PubMed ID: 25251584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidirectional myocardial systolic function in hemodialysis patients with preserved left ventricular ejection fraction and different left ventricular geometry.
    Wang H; Liu J; Yao XD; Li J; Yang Y; Cao TS; Yang B
    Nephrol Dial Transplant; 2012 Dec; 27(12):4422-9. PubMed ID: 22561582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Myocardial Fibrosis Using Multimodality Imaging in Severe Aortic Stenosis: Comparison With Histologic Fibrosis.
    Park SJ; Cho SW; Kim SM; Ahn J; Carriere K; Jeong DS; Lee SC; Park SW; Choe YH; Park PW; Oh JK
    JACC Cardiovasc Imaging; 2019 Jan; 12(1):109-119. PubMed ID: 30448148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial native-T1 times are elevated as a function of hypertrophy, HbA1c, and heart rate in diabetic adults without diffuse fibrosis.
    Lam B; Stromp TA; Hui Z; Vandsburger M
    Magn Reson Imaging; 2019 Sep; 61():83-89. PubMed ID: 31125612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncontrast Myocardial T1 Mapping by Cardiac Magnetic Resonance Predicts Outcome in Patients With Aortic Stenosis.
    Lee H; Park JB; Yoon YE; Park EA; Kim HK; Lee W; Kim YJ; Cho GY; Sohn DW; Greiser A; Lee SP
    JACC Cardiovasc Imaging; 2018 Jul; 11(7):974-983. PubMed ID: 29153562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygenation-sensitive cardiovascular magnetic resonance in hypertensive heart disease with left ventricular myocardial hypertrophy and non-left ventricular myocardial hypertrophy: Insight from altered mechanics and cardiac BOLD imaging.
    Chen BH; Wu R; An DA; Shi RY; Yao QY; Lu Q; Hu J; Jiang M; Deen J; Chandra A; Xu JR; Wu LM
    J Magn Reson Imaging; 2018 Nov; 48(5):1297-1306. PubMed ID: 29734491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac magnetic resonance imaging parameters show association between myocardial abnormalities and severity of chronic kidney disease.
    Jia X; Han X; Wang Y; He F; Zhou X; Zheng Y; Guo Y; Xu R; Liu J; Li Y; Gu J; Cao Y; Zhang C; Shi H
    Front Cardiovasc Med; 2022; 9():1053122. PubMed ID: 36465471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.